Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: If PTSC owned half the license - the the 3.5% should come only from TPL...
I should add my prior post is not meant to excuse contracts. We now see the issues almost 2 yrs after the fact. I do hope there are not other arrangements and hope Chet was the only one significantly involved contractually regarding licensing %s. Otherwise, how much is being syphoned off before PTSC gets its share?
Share
New Message
Please login to post a reply